Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.48 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2341243 | 0.87 | ABCB1 (0.50) | RXFP1ABCB1ABCG2CA12CA1 | |
| SCHEMBL13034146 | 0.85 | RXFP1 (0.49) | RXFP1ABCB1ABCG2CA12CA1 | |
| SCHEMBL113807 | 0.85 | IDO1 (0.59) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL28769967 | 0.84 | KMT2A (0.50) | RXFP1ABCB1ABCG2CA12CA1 | |
| SCHEMBL29272775 | 0.83 | KMT2A (0.43) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL4684928 | 0.81 | CA12 (0.55) | ABCB1ABCG2CA12CA1CA2 | |
| SCHEMBL490497 | 0.80 | KMT2A (0.47) | RXFP1ABCB1ABCG2CA12CA1 | |
| SCHEMBL7596038 | 0.80 | ABCB1 (0.46) | RXFP1ABCB1ABCG2KMT2AMEN1 | |
| SCHEMBL1032325 | 0.80 | CA12 (0.50) | ABCB1ABCG2CA12CA1CA2 | |
| SCHEMBL4369269 | 0.77 | ABCB1 (0.57) | ABCB1ABCG2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4323377-A1 | VACCINES | Adjuvance Technologies, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| WO-2023146892-A1 | BIPHENYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS | PARION SCIENCES, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146896-A1 | BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS | PARION SCIENCES, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023049218-A1 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | WAVE LIFE SCIENCES LTD. (SG) | 2023-03-30 | — | — | WO | disclosed |
| WO-2022256480-A1 | ARYLCOUMARIN SYNTHESIS WITH AZEOTROPIC REMOVAL OF WATER | CONAGEN INC. (US) | 2022-12-08 | — | — | WO | disclosed |
| EP-4061425-A1 | DIRECTED CONJUGATION TECHNOLOGIES | Kleo Pharmaceuticals, Inc. (US) | 2022-09-28 | — | — | EP | disclosed |
| EP-3993818-A2 | CD38-BINDING AGENTS AND USES THEREOF | Kleo Pharmaceuticals, Inc. (US) | 2022-05-11 | — | — | EP | disclosed |
| WO-2021234459-A9 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | WAVE LIFE SCIENCES LTD. (SG) | 2022-02-03 | — | — | WO | disclosed |
| CN-107148453-B | Photocurable composition | 思美定株式会社 | 2021-08-17 | — | — | CN | disclosed |
| WO-2021102052-A1 | DIRECTED CONJUGATION TECHNOLOGIES | KLEO PHARMACEUTICALS, INC. (US) | 2021-05-27 | — | — | WO | disclosed |
| CN-112805311-A | Curable composition, cured product, and method for producing cured product | 学校法人东京理科大学 | 2021-05-14 | — | — | CN | disclosed |
| CN-108431157-B | Bonding method using photocurable adhesive | 思美定株式会社 | 2021-02-05 | — | — | CN | disclosed |
| WO-2021003050-A2 | CD38-BINDING AGENTS AND USES THEREOF | KLEO PHARMACEUTICALS, INC. (US) | 2021-01-07 | — | — | WO | disclosed |
| CN-105392845-B | Photocurable composition | 思美定株式会社 | 2020-10-20 | — | — | CN | disclosed |
| CN-111201295-A | Photocurable adhesive composition and bonding method | 思美定株式会社 | 2020-05-26 | — | — | CN | disclosed |
| EP-3630199-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | Wave Life Sciences Ltd. (SG) | 2020-04-08 | — | — | EP | disclosed |
| CN-107532061-B | Pressure-sensitive adhesive | 思美定株式会社 | 2020-03-03 | — | — | CN | disclosed |
| WO-2018223056-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2018-12-06 | — | — | WO | disclosed |
| WO-2018053373-A1 | USES OF SATL-INDUCIBLE KINASE (SIK) INHIBITORS FOR TREATING OSTEOPOROSIS | THE GENERAL HOSPITAL CORPORATION (US) | 2018-03-22 | — | — | WO | disclosed |